ASH 2018 Emanuele Angelucci

Emanuele Angelucci, MD
Hematology and Transplant Center, IRCCS Ospedale Policlinico San Martino, Genova, Italy

 

Safety and Efficacy, Including Event-Free Survival, of Deferasirox Versus Placebo in Iron-Overloaded Patients with Low- and Int-1-Risk Myelodysplastic Syndromes (MDS): Outcomes from the Randomized, Double-Blind Telesto Study

 

https://ash.confex.com/ash/2018/webprogram/Paper111134.html

 

0119REV1100610
×

Ask Speakers

×

Medical Information Request